Get the Stockscreener App
235.08
3.93%
8.89
After Hours:
230.38
-4.70
-2.00%
Penumbra Inc stock is traded at $235.08, with a volume of 568.82K.
It is up +3.93% in the last 24 hours and down -8.19% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$226.19
Open:
$227.58
24h Volume:
568.82K
Relative Volume:
1.40
Market Cap:
$9.17B
Revenue:
$1.24B
Net Income/Loss:
$42.23M
P/E Ratio:
221.77
EPS:
1.06
Net Cash Flow:
$150.33M
1W Performance:
-0.18%
1M Performance:
-8.19%
6M Performance:
-20.58%
1Y Performance:
+2.43%
1-Day Range:
$227.37
$235.59
1-Week Range:
$221.26
$239.01
52-Week Range:
$221.26
$310.00
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
235.08 | 8.82B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
125.80 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.84 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.61 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.42 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Penumbra (NYSE:PEN) Sets New 1-Year LowShould You Sell? - MarketBeat
More data supports Penumbra mechanical thrombectomy system - MassDevice
Penumbra stock hits 52-week low at 222.24 USD By Investing.com - Investing.com Australia
Is Penumbra Inc. (0P8) stock a buy for dividend portfolios2025 Pullback Review & Real-Time Stock Price Movement Reports - newser.com
How Penumbra Inc. stock reacts to global recession fearsMarket Trend Report & Fast Exit Strategy with Risk Control - newser.com
Can Penumbra Inc. stock continue upward trend2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Penumbra’s thrombectomy treatment shows better outcomes for PE patients By Investing.com - Investing.com India
Custom watchlist performance reports with Penumbra Inc.2025 Winners & Losers & Long-Term Growth Stock Strategies - newser.com
What To Expect From Penumbra’s (PEN) Q3 Earnings - Yahoo Finance
Penumbra’s thrombectomy treatment shows better outcomes for PE patients - Investing.com
Penumbra (NYSE: PEN) Reports 472m vs 376m six-minute walk gains with CAVT in STORM-PE - Stock Titan
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary EmbolismPlatte Valley - Platte Valley - News Channel
Penumbra stock hits 52-week low at 222.24 USD - Investing.com
Does Penumbra Inc. stock trade at a discount to peersWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com
Why Penumbra’s Stock Faces a Downward Trend - TipRanks
Why Penumbra Inc. stock fits value portfoliosWeekly Trade Report & Low Risk Entry Point Guides - newser.com
Is Penumbra Inc. stock a contrarian opportunityWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
Should I hold or sell Penumbra Inc. stock in 2025July 2025 Macro Moves & Weekly High Return Opportunities - newser.com
How strong dollar benefits Penumbra Inc. stockJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - newser.com
Is Penumbra Inc. stock attractive for retirement portfoliosIndex Update & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Penumbra Inc. stock a top hedge fund pickMarket Volume Report & Capital Efficient Trade Techniques - newser.com
Pier Capital LLC Makes New $394,000 Investment in Penumbra, Inc. $PEN - MarketBeat
Why Penumbra Inc. stock is a strong buy callWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Will Penumbra Inc. stock attract ESG investorsEntry Point & High Conviction Trade Alerts - newser.com
Strs Ohio Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Teacher Retirement System of Texas Buys 2,078 Shares of Penumbra, Inc. $PEN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Penumbra, Inc. $PEN - MarketBeat
Wall Street Zen Downgrades Penumbra (NYSE:PEN) to Hold - MarketBeat
Penumbra Inc Stock Analysis and ForecastHealthcare Stock Analysis & Explosive Profit Growth - earlytimes.in
Penumbra, Inc. (PEN) Stock forecasts - Yahoo! Finance UK
Penumbra, Inc. (PEN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth - Investing.com Canada
Earnings call transcript: Penumbra’s Q2 2025 performance shows strong growth By Investing.com - Investing.com South Africa
Scholtz & Company LLC Raises Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. stock undervalued vs historical averages2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Brighton Jones LLC Acquires Shares of 1,177 Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors - MSN
Carret Asset Management LLC Sells 2,000 Shares of Penumbra, Inc. $PEN - MarketBeat
Hantz Financial Services Inc. Lowers Position in Penumbra, Inc. $PEN - MarketBeat
Is Penumbra Inc. (0P8) stock a momentum leaderEarnings Growth Summary & Technical Buy Zone Confirmations - newser.com
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):